Vaxess Technologies logo

Vaxess Technologies

Recent Finacing

Equity

Recent Raise

$9M


Vaxess Technologies is a life sciences company that is developing a sustained release patch technology for the stable, refrigeration-free administration of vaccines and therapeutics, with a current focus on mRNA vaccines.

Total Funding

$80M

Headquarters

Cambridge, USA

Founded

N/A

Website

Focus Areas

Life Sciences
mRNA Vaccine Development
Biotechnology

Investors

RA Capital logo
GHIC logo
Ulu Ventures logo
The Engine logo